Clinical trials
Phase 3 trials in Thailand
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,270 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 7 |
| 2002 | 10 |
| 2003 | 14 |
| 2004 | 20 |
| 2005 | 37 |
| 2006 | 36 |
| 2007 | 53 |
| 2008 | 67 |
| 2009 | 66 |
| 2010 | 64 |
| 2011 | 63 |
| 2012 | 58 |
| 2013 | 49 |
| 2014 | 57 |
| 2015 | 49 |
| 2016 | 37 |
| 2017 | 44 |
| 2018 | 58 |
| 2019 | 58 |
| 2020 | 62 |
| 2021 | 46 |
| 2022 | 56 |
| 2023 | 74 |
| 2024 | 72 |
| 2025 | 58 |
| 2026 | 45 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 785 |
| Active, not recruiting | 158 |
| Recruiting | 130 |
| Terminated | 127 |
| Unknown status | 48 |
| Enrolling by invitation | 8 |
| Not yet recruiting | 7 |
| Withdrawn | 6 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 128 |
| Hoffmann-La Roche | 108 |
| Novartis Pharmaceuticals | 108 |
| GlaxoSmithKline | 63 |
| Mahidol University | 55 |
| Merck Sharp & Dohme LLC | 54 |
| Boehringer Ingelheim | 42 |
| Novo Nordisk A/S | 41 |
| Pfizer | 31 |
| Bayer | 26 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 103 |
| Diabetes Mellitus, Type 2 | 70 |
| Breast Neoplasms | 58 |
| HIV Infections | 50 |
| Pulmonary Disease, Chronic Obstructive | 29 |
| Arthritis, Rheumatoid | 24 |
| Carcinoma, Hepatocellular | 24 |
| Asthma | 23 |
| Diabetes Mellitus | 21 |
| Neoplasms | 21 |
Trials
Showing 1 to 25 of 1,270. Each trial links to its page on Pharma Observatory.
1,170 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.